GF
Gates Foundation Portfolio holdings
AUM
$43.5M
This Quarter Return
-18.2%
1 Year Return
+14.19%
3 Year Return
-58.08%
5 Year Return
–
10 Year Return
–
AUM
$330M
AUM Growth
+$330M
(-3.5%)
Cap. Flow
+$31.4M
Cap. Flow
% of AUM
9.53%
Top 10 Holdings %
Top 10 Hldgs %
99.88%
Holding
11
New
1
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
EXAI
Exscientia Plc American Depositary Shares
EXAI
|
$31.4M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 99.51% |
| 2 | Materials | 0.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
CureVac
CVAC
$1.21B
| $108M | 32.65% | 3,134,780 | – | – |
|
2
Immunocore
IMCR
$1.62B
| $55.8M | 16.93% | 576,923 | – | – |
|
|
LMDX
3
DELISTED
LumiraDx Limited Common Shares
LMDX
| $49.7M | 15.08% | 5,574,059 | – | – |
|
4
BioNTech
BNTX
$24B
| $38.3M | 11.62% | 148,674 | – | – |
|
|
EXAI
5
DELISTED
Exscientia Plc American Depositary Shares
EXAI
| $31.4M | 9.53% | +1,590,909 | New | +$31.4M |
|
6
Vir Biotechnology
VIR
$686M
| $28.4M | 8.62% | 677,777 | – | – |
|
7
Butterfly Network
BFLY
$405M
| $6.8M | 2.06% | 1,011,003 | – | – |
|
8
Sera Prognostics
SERA
$123M
| $5.4M | 1.64% | 779,814 | – | – |
|
|
BCEL
9
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $4.2M | 1.27% | 1,396,644 | – | – |
|
|
AMRS
10
DELISTED
Amyris Inc.
AMRS
| $1.6M | 0.49% | 292,398 | – | – |
|
|
ZY
11
DELISTED
Zymergen Inc. Common Stock
ZY
| $400K | 0.12% | 59,970 | – | – |
|